CLX

85.8500.30%

Weekly Recap | Clorox -5.7%, Wells Fargo trims expectations

LongbridgeAII'm LongbridgeAI, I can summarize articles.

Clorox finished the week down 5.7% at $87.76, while the S&P 500 lost 0.8%, meaning the stock lagged the index by about 4.9 percentage points. The decline was fairly steady: after opening at $92.81 on Tuesday and marking the week’s high, the shares fell in each of the following three sessions. Friday carved out the week’s low at $85.72 before closing at $87.76. Weekly amplitude came to 8.76%, and average daily volume of roughly 3.61m shares ran about 54% above the recent median.

The Week

Clorox finished the week down 5.7% at $87.76, while the S&P 500 lost 0.8%, meaning the stock lagged the index by about 4.9 percentage points. The decline was fairly steady: after opening at $92.81 on Tuesday and marking the week’s high, the shares fell in each of the following three sessions. Friday carved out the week’s low at $85.72 before closing at $87.76. Weekly amplitude came to 8.76%, and average daily volume of roughly 3.61m shares ran about 54% above the recent median. Friday’s volume of 6.21m shares dwarfed the 2.70m to 2.78m seen earlier in the week, suggesting selling pressure picked up into the close.

Key Events

Company-specific news was thin, and what did surface leaned negative. On Wednesday 9 September, one item highlighted timing solutions, network resilience, and a steady FY27 outlook for Clorox, which reads more like an operational update than an upgrade to financial guidance. The same day, a separate piece noted passive income investors buying five well-known high-yield stocks near 52-week lows, with Clorox among them — a sign that its yield is drawing some attention as the price falls. On Friday 11 September, Wells Fargo lowered its expectations for Clorox shares, coinciding with the session’s intraday low of $85.72. Taken together, the week lacked a major catalyst from the company itself, with the tape driven largely by external rating adjustments and cautious sentiment across the consumer staples space.

Analyst Ratings

Among 20 institutions covering Clorox, one rates it buy, 14 rate it hold, two rate it underperform, two rate it sell, and one has no opinion; none rate it overweight. The consensus rating is hold, with a consensus target of $100.76, about 14.8% above the latest price. Individual targets range from $77 to $154, a wide band that points to meaningful disagreement about the path ahead. Within its industry group, the stock ranks fourth out of 12 by rating, which places it among the more favourably rated names. Overall, the house view is neutral, with targets above spot but dispersion on the high side.

The Week Ahead

The coming week brings a batch of US retail and manufacturing data. Tuesday 15 September features the New York Fed manufacturing index, with a prior reading of 20.6 and a consensus estimate of 14.75. Wednesday 16 September is busier, with retail sales ex-autos, import price index, retail control, headline retail sales, and the NAHB housing market index. Headline retail sales carried a prior print of -0.6% and a forecast of 0.9%; a weak number could add pressure to consumer-staples valuations. For Clorox, home cleaning products are tied to consumer resilience, so retail and housing prints offer a read on underlying demand. EIA weekly crude and Cushing inventory data also land midweek, relevant to input-cost trends.

In Short

Clorox opened the week with a steady grind lower and closed with a sharp Friday sell-off. The valuation snapshot shows a P/E of roughly 18x alongside a very high P/B near 118x and a 5.66% dividend yield, a mix that reflects a thin book but resilient cash generation. On the latest trading day, large-lot money was a net seller while small and medium lots were net buyers, pointing to institutional exits met by retail absorption. The consensus rating is hold and the consensus target sits above spot, but targets are widely dispersed. The key question ahead is whether US retail and housing data stabilise sentiment for consumer staples, or whether the recent de-rating carries into the next week.

This article is generated by LongbridgeAI from market data, for information only and not investment advice.

Source: Weekly Review The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.